GlassScriptPhysician profile
Zhangliang Ma
NPI 1508158106
$5,032.39
in general payments reported to CMS, 2019-2025
21 companies · $1,631 in 2025
The $1,631 reported for 2025 was more than what 81% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,122 · 2020: $70.29 · 2021: $280 · 2022: $432 · 2023: $996 · 2024: $502 · 2025: $1,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983 · Travel and Lodging: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.35 |
| Travel and Lodging | $1,144.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,024.18 | 2023-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Nevro Corp. | $1,719.28 | 2019-2024 | Senza |
| Stryker Corporation | $535.71 | 2025 | Mild Device Kit, Omnicurve |
| Abbvie INC. | $285.31 | 2021-2025 | |
| Boston Scientific Corporation | $74.45 | 2024-2025 | Intracept |
| Amgen INC. | $67.42 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $36.33 | 2021 | |
| Pfizer INC. | $29.24 | 2019 | |
| Globus Medical, INC. | $28.53 | 2025 | Senza |
| Supernus Pharmaceuticals, INC. | $28.42 | 2019-2020 | |
| Spr Therapeutics, INC | $25.10 | 2023 | Sprint Pns System |
| Bayer Healthcare Pharmaceuticals INC. | $24.80 | 2020 | |
| Pacira Therapeutics, INC. | $23.99 | 2019 | |
| Averitas Pharma INC. | $23.14 | 2024 | Qutenza |
| Redhill Biopharma INC. | $19.48 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.62 | 2020 | |
| Horizon Therapeutics Plc | $15.12 | 2022 | |
| Si-Bone, INC. | $15.04 | 2022 | |
| Lilly USA, LLC | $14.57 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $14.32 | 2021 | |
| Stimwave Technologies Incorporated | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zhangliang Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.